17q12 Knowledge Basedeletion syndrome · static snapshot
Adults Scientists Kids EN NL
All content was collected from public internet sources and processed with the help of AI/LLM software. This site is informative only — do not draw conclusions; verify with the original sources. Full disclaimer
New publication Day-to-day care 1 supporting source confidence 97% novelty 75%

Treatment Options for Patients with Maturity-Onset Diabetes of the Young (MODY): A Systematic Review of Literature: 2026 Update

Treatment Options for Patients with Maturity-Onset Diabetes of the Young (MODY): A Systematic Review of Literature: 2026 Update INTRODUCTION: Maturity-onset diabetes of the young (MODY) is a rare monogenic form of diabetes characterized by impaired insulin secretion and genetic and clinical heterogeneity.

More new publication

How this was derived

Indexed from **openalex** on 2026-11-13 (relevance 0.56, tier peer_reviewed).

Generated 2026-11-13, last changed yesterday. Dedup key newdoc:549. The engine re-checks this insight on every analysis run; if more sources agree, its corroboration and confidence go up and it reappears as “new”.

Evidence (1 quote)

Treatment Options for Patients with Maturity-Onset Diabetes of the Young (MODY): A Systematic Review of Literature: 2026 Update peer_reviewed · published 2026-06-15 · live page
Glucokinase (GCK)-MODY remains managed without pharmacological treatment outside pregnancy, but dorzagliatin, a novel agent acting as a glucokinase activator, may further expand precision treatment approaches.

Supporting documents (1)

DocumentSourcePublishedSeenRelevance
Treatment Options for Patients with Maturity-Onset Diabetes of the ... openalex 2026-06-15 yesterday 0.56